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Abstract
Localization of CAP-Gly proteins such as CLIP170 at microtubule+ends results from their dual interaction with a-tubulin and
EB1 through their C-terminal amino acids 2EEY. Detyrosination (cleavage of the terminal tyrosine) of a-tubulin by tubulin-
carboxypeptidase abolishes CLIP170 binding. Can detyrosination affect EB1 and thus regulate the presence of CLIP170 at
microtubule+ends as well? We developed specific antibodies to discriminate tyrosinated vs detyrosinated forms of EB1 and
detected only tyrosinated EB1 in fibroblasts, astrocytes, and total brain tissue. Over-expressed EB1 was not detyrosinated in
cells and chimeric EB1 with the eight C-terminal amino acids of a-tubulin was only barely detyrosinated. Our results indicate
that detyrosination regulates CLIPs interaction with a-tubulin, but not with EB1. They highlight the specificity of
carboxypeptidase toward tubulin.
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Introduction
Microtubules are hollow tubes composed of a- and b-tubulin
heterodimers, which are essential for cell morphogenesis, division,
and motility and for intracellular motile events. They are
intrinsically polar structures with a predominantly stable minus
end and a highly dynamic plus end. Several proteins called plus-
end tracking proteins (+TIPs) associate specifically with growing
microtubule+ends where they regulate microtubule dynamic
parameters and interactions with other cellular elements like
organelles, cell cortex, or actin filaments [1,2]. +TIPs can bind to
each other and form dynamic complexes at microtubule ends.
Among +TIPs, EB1 is a small homodimeric protein of 30 kDa
considered to form the core of the microtubule+end complexes.
EB1 interacts directly through a consensus polypeptide motif Ser-
x-Ile-Pro (SxIP) with the majority of the other known +TIPs,
recruiting them to microtubule+ends [2,3]. However, the CAP-
Gly-containing proteins (CLIP-170, CLIP-115, p150Glued),
which are also targeted to microtubule+ends by EB1, bind
differently to this core protein. The interaction between EB1 and
the CLIPs occurs through the C-terminus part of EB1 which
terminates in an acidic tail with the amino acids sequence 2EEY
[4,5]. It has been shown in vitro that this interaction requires the
terminal aromatic residue tyrosine of EB1, since a mutant form of
EB1 lacking the tyrosine only weakly binds to CLIP170 [6] and an
EB1 mutant in which the tyrosine was replaced by an alanine is
unable to bind CLIP-170 [7].
Besides its localization at microtubule+ends via EB1, CLIP-170
was also shown to directly recognize and bind to microtubule-
s+ends in mammals and in S. Cerevisiae [8,9,10]. This direct
interaction involves the C-terminal region of a-tubulin via a small
C-terminal 2EEY motif which displays a striking homology with
the C-terminus of EB1. Importantly the last tyrosine residue of a-
tubulin has been shown to be crucial for CLIP 170 binding.
Indeed, a-tubulin is subjected to a detyrosination-tyrosination
cycle in which the terminal tyrosine is removed by a carboxypep-
tidase (TCP) and re-added by Tubulin Tyrosine Ligase (TTL). In
TTL deficient cells, abnormally enriched in detyrosinated tubulin,
CLIP 170 binding to microtubules+ends is heavily reduced [9].
Similarly, in a S. Cerevisiae mutant strain expressing a detyrosinated
form of a-tubulin, the homologue of CLIP-170 (Bik1p) cannot
properly track microtubule ends [8]. Thus, CLIP 170 interaction
with both EB1 and a-tubulin involves their 2EEY C-terminal
motifs and particularly their last tyrosine residue. The presence of
CLIPs at microtubule+ends, which depend on their interaction
with a-tubulin and with EB1, is necessary for normal microtubules
interactions with the cell cortex; these connections being crucial
for spindle positioning during mitosis and for neuronal polariza-
tion [9,11]. Defective interactions of CLIPs at microtubules+ends
may thus at least partly explain tumor progression of numerous
cancers involving cells which lack TTL enzyme [12]. They also
give molecular explanation for deleterious neuronal disorganiza-
tion of TTL-deficient mouse [13].
As detyrosination of a-tubulin is one way to regulate the
presence of CLIP170 protein at microtubule+end, we wondered
whether EB1 detyrosination could also control CLIP 170
targeting, i.e. if EB1 could be detyrosinated in cells. To determine
the possible occurrence of detyrosinated EB1, we developed highly
specific anti-peptide antibodies directed against the tyrosinated
form and presumed detyrosinated form of EB1. We show that
mouse fibroblasts, astrocytes, and brain do not contain detectable
amounts of detyrosinated EB1, even when we used TTL-deficient
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residues of EB1 with those of a-tubulin leads only to a near to the
ground detyrosination of EB1 chimera. These results strongly
suggest that EB1 is never detyrosinated in normal tissues and
indicate that EB1 interaction with CLIPs is not regulated by
detyrosination. These results exclude an involvement of EB1
detyrosination to explain TTL-deficient cell and mouse pheno-
types. Additionally, our results highlight the high specificity of
tubulin carboxypeptidase toward tubulin.
Results and Discussion
Specific antibodies against tyrosinated EB1 and putative
detyrosinated EB1
To have tools to study the possible occurrence of detyrosinated
EB1 in cells and tissues, we developed polyclonal antibodies
directed against antigenic peptides designed from the eight
terminal amino acids of EB1 with and without the terminal
tyrosine: PQEEQEEY (for anti-tyrosinated EB1 named anti-Tyr
EB1) and GPQEEQEE (for anti-detyrosinated EB1 named anti-
deTyr EB1). Sera from rabbits for anti-Tyr EB1 and from guinea
pigs for anti-deTyr EB1 were tested for dilution and specificity by
both Western blotting and immunocytochemistry.
Figure 1A shows Western-blots obtained with anti-Tyr EB1,
anti-deTyr EB1, and a commercial anti-EB1 (raised against
amino-acids 107–268 of mouse EB1). Antibodies were tested on
purified tyrosinated EB1 (over-expressed in E. coli) and detyr-
osinated EB1 (obtained from expressed tyrosinated EB1 using
carboxypeptidase A). Whereas the commercial anti-EB1 (1:2000)
stained both forms of EB1, anti-Tyr EB1 (1:15000) stained only
tyrosinated EB1, and anti-deTyr EB1 (1:200) stained only
detyrosinated EB1. The commercial anti-EB1 was thus called
anti-total EB1. To assay the specificity of the new EB1 antibodies,
we also tested them on tyrosinated and detyrosinated forms of
tubulin (obtained from mouse brain using tubulin tyrosine ligase
and carboxypeptidase A). Although the EB1 and a-tubulin C-
terminal sequences shared four amino acids out of eight, anti-Tyr
EB1 and anti-deTyr EB1 did not react with tubulin. In the
controls with tubulin antibodies (Fig. 1A lower part), we observed
that YL1/2 [14] reacted not only with tyrosinated tubulin but also
strongly with tyrosinated EB1 as expected [15]. Anti detyrosinated
tubulin antibody [16,17] is highly tubulin specific.
We then tested the developed antibodies in immunocytochem-
istry experiments. Fibroblasts were transfected with either
tyrosinated EB1 or a mutant form of EB1 missing the last tyrosine
(detyrosinated EB1), both fused to GFP at the N-terminus. Anti-
Tyr EB1 (1:1000) was shown to be highly specific: it strongly
reacted with tyrosinated EB1 (GFP-Tyr EB1), but not with
detyrosinated EB1 (GFP-deTyr EB1) (Figure 1B). Anti-deTyr EB1
was not reactive in immunocytochemistry experiments (data not
shown).
Next, we analyzed the staining of endogenous EB1 within
different mouse cell types. Anti-Tyr EB1 nicely stained all
examined cells, including fibroblasts, astrocytes, and neurons.
Figure 1C shows typical immunofluorescent labeling of endoge-
nous EB1 from astrocytes obtained with anti-Tyr EB1 antibody
(1:1000). We observed selective accumulation of EB1 in comets at
the microtubule plus ends during cell interphasis and decoration of
mitotic spindle during cell mitosis. Staining of tyrosinated EB1 co-
localized with staining with the commercial anti-EB1 antibody
(anti-total EB1).
Altogether our results show that the antibodies we have
developed against tyrosinated EB1 and putative detyrosinated
EB1 are highly specific and are useful in Western-blot experi-
ments. We then used them to examine the possible occurrence of
the detyrosinated form of EB1 in mouse cells and tissues. We
analyzed potential EB1 detyrosination in wild type fibroblasts and
in brain, a tissue in which normally the majority of a tubulin is
detyrosinated (see Figure 2C). As EB1 detyrosination could be
mediated either by an unknown carboxypeptidase or by the TCP
in unusual conditions where its natural substrate (tyrosinated
tubulin) is largely decreased (see Figure 2C), we decided to also
examine TTL-deficient fibroblast and brain.
Endogenous EB1 is fully tyrosinated in wild type and TTL-
deficient mouse fibroblasts and brain
We first prepared crude extracts of fibroblasts from wild type
and TTL-deficient mice and concentrated their endogenous EB1
by immunoprecipitation using commercial anti-EB1 (which
interacts equally with tyrosinated and detyrosinated EB1, as
shown in Fig. 1A). Figure 2A clearly shows that EB1 from both cell
types was entirely tyrosinated: whereas anti-Tyr EB1 signals were
high in the immunoprecipitated fractions, no staining could be
detected in these fractions with anti-deTyr EB1.
Next, we tested brain extracts from wild type and TTL-deficient
mouse. After immunodepletion of Tyr EB1 using the antibody
developed in the present work (IP1 to 4), we tested for the presence
of the detyrosinated form of EB1 in the remaining extracts by
immunoprecipitation with anti-total EB1 (IP5). Figure 2B shows
that no other form of EB1 than tyrosinated EB1 could be detected
in both wild type and TTL knock-out brain extracts.
Based on these data, we concluded that EB1 protein is fully
tyrosinated in fibroblasts and brain from both wild type and TTL-
deficient mice. EB1 C-terminus is not subjected to detyrosination
even in TTL-deficient cells and in tissues in which the level of
tyrosinated tubulin (the substrate of TCP) is decreased. To
strengthen our results, we next decided to test if overexpressed
EB1 could be modified in cells, and also if changing the eight C-
terminal amino-acids PQEEQEEY of EB1 to a-tubulin amino-
acids GEEEGEEY could lead to cellular detyrosination of
chimeras.
EB1 with the C-terminus of a-tubulin is barely
detyrosinated
Fibroblasts (NIH3T3) were transfected with plasmids allowing
expression of either GFP-EB1 (tyrosinated EB1 with GFP at the
N-terminus) or GFP-EB1-CterTub (mutated EB1 with GFP at the
N-terminus and ending with the amino-acids sequence of a-
tubulin GEEEGEEY). After 48 hours of transfection, crude
extracts of cells were prepared, and transfected proteins were
immunoprecipitated using mouse anti-GFP. First, C-termini of
GFP-EB1 proteins were analyzed by Western-blot using anti-Tyr
EB1 and anti-deTyr EB1. Figure 3A presents a typical experiment
that clearly shows that GFP-EB1 remained entirely tyrosinated in
the fibroblasts. Note that endogenous EB1 co-immunoprecipitated
with GFP-EB1. Second, C-termini of GFP-EB1-CterTub proteins
were analyzed with antibodies against tubulin C-termini, anti-Tyr
Tub (YL1/2), and anti-deTyr Tub (L4). In these experiments,
endogenous tubulin was thus stained together with GFP-EB1-
CterTub. Figure 3B presents the results obtained using both wild
type (NIH3T3) and TTL-deficient fibroblasts. Anti-Tyr Tub
antibody allows detection of Tyr Tub in supernatant and of GFP-
EB1-Cter-Tub (having a slightly higher molecular weight) in
immunoprecipitated (IP) fraction in both wild type and TTL-
deficient cells. Anti deTyr Tub antibody allows detection of low
levels of deTyr Tub in wild type cells and of large levels of deTyr
Tub in TTl-deficient cells (see crude extracts and supernatants), as
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CterTub in these cells, comparable in TTL-deficient and wild type
cells (see IP fractions, upper bands). The quantity of detyrosinated
EB1-CterTub was estimated to represent less than 4% of
overexpressed mutated EB1. The reactivity of the tubulin
antibodies with GFP-EB1-CterTub was verified: after incubation
Figure 1. Analysis of developed anti-EB1 antibodies compared to the known anti-tubulin antibodies. (A) Western-blot analysis of the
indicated proteins (15 ng) separated on 10% SDS-PAGE using a commercial anti-EB1 antibody (anti-total EB1, raised against amino-acids 107–268 of
mouse EB1), the presently developed antibodies (anti-Tyr EB1 and anti-deTyr EB1), and tubulin antibodies. Detyrosinated EB1 was obtained from
recombinant EB1 using carboxypeptidase A. Tyrosinated and detyrosinated tubulin were obtained from purified brain tubulin, using respectively TTL
and carboxypeptidase A. Both anti-Tyr EB1 and anti-deTyr EB1 are highly specific. (B) Double immunostaining with anti-total EB1 antibody and anti-
Tyr EB1 on fibroblasts after transfection of plasmids allowing expression of either tyrosinated or detyrosinated EB1 with EGFP at the N-terminus. The
transfected cells were detected by EGFP signal. Anti-Tyr EB1 is highly specific of tyrosinated form of EB1. (C) Immunostaining of endogenous EB1 in
astrocytes with anti-Tyr EB1 and anti-total EB1.
doi:10.1371/journal.pone.0033490.g001
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anti-Tyr Tub (YL1/2) signal completely disappeared, and staining
was observed using anti-deTyr Tub (L4) (data not shown).
We concluded that EB1 is not a substrate for the tubulin-
modifying enzyme TCP, and that a mutated EB1 that ends with
the eight C-terminal residues of a-tubulin (EB1-CterTub) is a very
poor substrate for this enzyme.
Altogether, our results establish that EB1 can be detected only
on a tyrosinated form in the cells and tissues we tested. EB1 is fully
tyrosinated in brain, a tissue in which tubulin is highly
detyrosinated. Even in TTL null cells or tissue where the amount
of normal TCP substrate (tyrosinated tubulin) is largely dimin-
ished, conditions favorable for TCP action on alternative
substrates, we still only detected tyrosinated EB1. Hence, EB1
detyrosination seems unlikely involved in the defective recruitment
of CAP-Gly proteins at microtubule plus ends in TTL null cells
and thereby do no not contribute to the lethal phenotype observed
in mice after TTL deletion.
To summarize, no enzyme, including TCP, seems capable of
cleaving the C-terminal tyrosine of EB1 within cells. As a
consequence, whereas detyrosination of the C-terminal part of
a-tubulin by the TCP enzyme crucially regulates CLIP-170
localization at microtubules+ends, end-tracking of CLIP-170 via
EB1 does not depend on EB1 detyrosination.
Materials and Methods
Antibodies
Polyclonal antibodies against tyrosinated EB1 (anti-Tyr EB1)
wereproduced in rabbits by usingpeptide PQEEQEEY linked at its
N-terminustotheKeyholeLimpetHemocyanine(KLH)proteinvia
a cystein. Polyclonal antibodies against detyrosinated EB1 (anti-
deTyr EB1) were produced in guinea pigs by using KLH-
CGPQEEQEE. Anti-total EB1 (mouse monoclonal IgG antibody
against the C-terminal part of EB1, amino-acids 107–268) was from
BD Biosciences. Antibodies specific to tyrosinated tubulin (mouse
Figure 2. Study of endogenous EB1 C-termini in fibroblasts and brain from wild type and TTL-deficient mouse. Western-blot analysis
of the indicated control proteins (see figure 1) or extracts. (A) Immunoprecipitation of endogenous EB1 from wild type (TTL
+/+) or TTL-deficient MEFs
using anti-total EB1 antibody, and analysis with anti-Tyr EB1 (1:15000), anti-detyr EB1 (1:200), and anti-total EB1 (1:2000). EX: crude extract; SN:
supernatant after immunoprecipitation; IP: immunoprecipitated fraction. No detyrosinated EB1 could be detected in the IP fractions. Note that anti-
total EB1 antibody being less sensitive than anti-Tyr EB1, EB1 failed to be detected in crude extract (upper panel). (B) Immunodepletion of tyrosinated
EB1 with anti-Tyr EB1 (IP 1 to 4) in brain extracts from wild type and TTL-knockout mice, followed by immunoprecipitation of the remaining EB1 with
anti-total EB1 (IP5), and analysis with anti-total EB1 (1:2000). No remaining EB1 could be detected after tyrosinated-EB1 immunodepletion. (C)
Tyrosinated and detyrosinated tubulin pools in brain extracts from wild type and TTL-deficient mice were analyzed using anti-a tubulin (1:10,000),
anti-tyrosinated tubulin (YL1/2, 1:20,000), and anti-detyrosinated tubulin (L4, 1:20,000).
doi:10.1371/journal.pone.0033490.g002
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L4, developed in rabbits) were kind gifts of L. Lafaneche `re [17].
Antibody against a-tubulin was from mouse clone a3A1 [13].
Mouse anti-GFP was from Invitrogen. Anti-rabbit, anti-mouse, and
anti-guinea pigantibodies taggedwitheithercyanine-5or cyanine-3
were from Jackson Immuno Research, and anti-rabbit, anti-mouse
and anti-guinea pig antibodies tagged with horse radish peroxidase
(HRP) were from Macherey Nagel.
Figure 3. Analysis of C-termini of recombinant EB1 forms overexpressed in wild type and TTL-deficient fibroblasts. Western-blot
analysis of the indicated control proteins (see figure 1) and of fractions of immunoprecipitation experiments carried out on cells transfected with
cDNA encoding different EB1 forms. EX: crude extract; SN: supernatant after immunoprecipitation; IP: immunoprecipitated fraction. (A) transfection of
fibroblasts (NIH3T3) with plasmids encoding tyrosinated EB1 fused with GFP at the N-terminus (GFP-EB1), followed by immunoprecipitation using
anti-GFP antibody and analysis using anti-Tyr EB1 (1:15000) and anti-deTyr EB1 (1:200). No detyrosinated GFP-EB1 could be detected. (B) Transfection
of fibroblasts with cDNA encoding GFP-EB1 ending with the C-terminus of a-tubulin GEEEGEEY (GFP-EB1-CterTub), followed by immunoprecipitation
with anti-GFP antibody and analysis using anti-Tyr Tub (1:20,000) and anti-deTyr Tub (1:20,000). NIH3T3 were used as TTL
+/+ cells and MEFs isolated
from TTL null mice were used as TTL
2/2. A very low quantity of detyrosinated protein ending with a-tubulin residues was detected (upper band in IP
fractions of lower panel).
doi:10.1371/journal.pone.0033490.g003
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Tyrosinated and detyrosinated tubulin were prepared according
to [18]. In brief, tubulin was purified from bovine brains and
incubated with either tubulin tyrosine ligase (kind gift of M.
Steinmetz) to obtain tyrosinated tubulin (Tyr Tub) or carboxy-
peptidase A (Sigma) to obtain detyrosinated tubulin (deTyr Tub).
EB1 (Tyr EB1) was obtained by overexpression of mouse EB1
fused to a 6-histidines cluster at its N-terminus in E. coli and
purification on a nitrilotriacetate-Ni
2+ adsorbent (Qiagen). Detyr-
osinated EB1 (deTyr EB1) was obtained by incubation of purified
EB1 with carboxypeptidase A. Protein concentration was
determined by the method of Bradford using bovine serum
albumin as standard.
Mouse Experiments
In compliance with the European Community Council
Directive of November 24, 1986 (86/609/EEC), research
involving animals has been authorized by the Direction De ´parte-
mentale de la Protection des Populations, Pre ´fecture de l’Ise `re,
France (permit nu38 07 11). Every effort was made to minimize the
number of animals used and their suffering. This study has been
approved by the local ethics committee of Grenoble Institut des
Neurosciences. For tissue preparation or cell culture, mice were
sacrificed and organs were quickly dissected.
Cell culture and immunofluorescence
Hippocampal neurons and murine embryonic fibroblasts
(MEFs) were prepared as previously described [13]. Astrocytes
were obtained from cerebral cortices of 18-day mice fetuses. Cells
were fixed by 10 min incubation with methanol at 220uC. They
were then incubated with rabbit anti-Tyr EB1 (1:2000), guinea-pig
anti-deTyr EB1 (1/10 to 1/200), or mouse anti-total EB1 (1:500,
BD Transduction laboratories) for 1 h, followed by 30 min
incubation with anti-rabbit, anti-guinea pig, or anti-mouse
antibodies conjugated with either cyanine-3 or cyanine-5 fluor-
ophores (1:1,000; Molecular Probes). Nuclei were stained using
Hoescht 33258 (1 mg/ml). Images were acquired using Axioskop
50 (Carl Zeiss MicroImaging) microscopes and Metamorph
(Universal Imaging Corp., USA) software.
Expression constructs and cell transfections
Vector pEGFP-C3 (BD bioscience Clontech) was used to
construct plasmids allowing expression of the EB1 proteins fused
to GFP at their N-terminus: GFP-Tyr EB1, GFP-deTyr EB1, and
GFP-EB1-CterTub (with EB1 eight C-terminal amino-acids
replaced by the residues of a-tubulin). In brief, cDNA of mouse
EB1 (Tyr EB1) was obtained with mRNA prepared from mouse
brain using Superscript One-Step RT-PCR kit (Invitrogen) and
was cloned between SacI and SacII restriction sites of pEGFP-C3
to create pEGFP-Tyr EB1. This plasmid was modified using PCR
(between HindIII and SacII restriction sites) to construct pEGFP-
deTyr EB1 (missing the last codon coding for the tyrosine) and to
create pEGFP-EB1-CterTub. All constructs were verified by
restriction digestions and DNA sequencing analysis. Cells were
then transfected using Nucleofector kits (Amaxa Biosystems).
Immunoprecipitation and Immunoblotting
Fibroblasts and brain lysates were obtained by extraction in
50 mM Tris at pH 8.0, 150 mM NaCl, 0.05% deoxycholate, 1%
Triton X-100, 10% glycerol, protease inhibitors (complete Mini
EDTA free, Roche diagnostics), and DNase (0.1 mg/mL), followed
by centrifugation (13,000 g 3 min). For immunoprecipitation,
fibroblast lysates were incubated 90 min at 4uC in 50 mM Tris at
pH 8.0, 150 mM NaCl, 0.04% deoxycholate, 0,8% Triton X-100,
8% glycerol, protease inhibitors, and DNase with either mouse
anti-total EB1 or mouse anti-GFP antibodies pre-incubated
overnight with Ultralink immobilized protein G beads (PIERCE).
After centrifugation at 13,000 g for 2 min, the immunoprecipitates
were washed three times with 50 mM Tris at pH 8.0, 150 mM
NaCl, 0.05% Triton X-100, and protease inhibitors. For
immunodepletion, brain lysates were incubated 90 min at 4uC
in 50 mM Tris at pH 8.0, 150 mM NaCl, 0.03% deoxycholate,
0.6% Triton X-100, 6% glycerol, protease inhibitors, and DNase
with anti-total EB1 antibody pre-incubated 60 min with protein G
beads (PIERCE). After centrifugation at 13,000 g for 3 min, the
supernatant was used for a novel immunoprecipitation with the
same antibody in the same conditions, and this was repeated three
times (IP1-4). The fifth immunoprecipitation (IP5) was then
performed in the same experimental conditions with anti-Tyr
EB1. Proteins were resolved on 10% SDS-PAGE followed by
electrotransfer to Immobilon P sheets (Millipore). Primary
antibodies (see Fig. 2 and Fig. 3) were incubated and the blots
were then stained with secondary antibodies coupled to horserad-
ish peroxidase. The reactive proteins were detected using Pierce
ECL Substrate (ThermoScientific) followed by exposure to
hyperfilm MP (Fisher Scientist).
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